Within-subject biological variation in disease: collated data and clinical consequences

Carmen Ricós, Natàlia Iglesias, José-Vicente García-Lario, Margarita Sánchez Simón, Fernando Cava, Amparo Hernández, Carmen Perich, Virtudes Álvarez, Maria-Vicenta Doménech, Carlos-Victor Jiménez,

Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2007 · 190 citations · 29 references

Concepts

TL;DR

Quantitative data on biological variation are used to calculate reference change values for serial results, and pathology can alter both the set point and the variation around it. The study collates all published within‑subject biological variation data for disease states other than health. The authors report within‑subject coefficients of variation for 66 quantities in 34 diseases, compare them to healthy values, and evaluate their clinical usefulness. Most quantities exhibit similar variation in disease and health, so healthy‑derived reference change values are generally adequate, but for a few disease‑specific markers the variation differs, indicating that disease‑specific reference change values may be clinically useful.

Abstract

Quantitative data on the components of biological variation (BV) are used for several purposes, including calculating the reference change value (RCV) required for the assessment of the significance of changes in serial results in an individual. Pathology may modify the set point in diseased patients and, more importantly, the variation around that set-point. Our aim was to collate all published BV data in situations other than health. We report the within-subject coefficient of variation (CV(I)) for 66 quantities in 34 disease states. We compared the results with the CV(I) determined in healthy individuals and examined whether the data derived in specific diseases could be useful for clinical applications. For the majority of quantities studied, CV(I) values are of the same order in disease and health: thus the use of RCV derived from healthy subjects for monitoring patients would be reasonable. However, for a small number of quantities considered to be disease specific markers, the CV(I) differed from those in health. This could mean that RCV derived from healthy CV(I) may be inappropriate for monitoring patients in certain diseases. Hence, disease-specific RCVs may be clinically useful.

References

29